The 14-bp insertion/deletion as a promising gene polymorphism to understand cancer risk: Evidence from a systematic review and comprehensive meta-analysis.

Heliyon · 2024 · PMC11599971 · PMID 39605806

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

not) revealed highly significant risks of the 14-bp deletion variant in cancer patients with concomitant viral infection with either human papillomavirus (HPV) or hepatitis B virus (HBV) or hepatitis C virus (HCV) under the D vs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.